Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF02723754 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Does strengths of a positive direct antiglobulin test predicts the need for phototherapy and duration of phototherapy? - a single center, retrospective study.
J Matern Fetal Neonatal Med
December 2023
Transfusion, South Tees Pathology, James Cook University Hospital, Middlesbrough, UK.
Background: Use of Direct Antiglobulin test (DAT) in management of neonatal hyperbilirubinemia is conflicting.
Objective: whether strength of positive DAT predicts the need for phototherapy, duration of phototherapy and need for major interventions.
Methods: We retrospectively collected data on all DAT positive neonates with birth gestational age ≥32 weeks over six years (2014-2019).
Reducing the Time to Action on Bilirubin Results Overnight in a Newborn Nursery.
Pediatr Qual Saf
December 2023
From the Department of Pediatrics, NYU Langone Hospital Long Island, Mineola, New York.
Introduction: Infants commonly require phototherapy in the nursery to prevent kernicterus, but it can interfere with parent-infant bonding. Minimizing unnecessary phototherapy is important. We noticed frequent delays in initiating and discontinuing phototherapy at our hospital.
View Article and Find Full Text PDFSevere neonatal hyperbilirubinaemia: lessons learnt from a national perinatal audit.
Arch Dis Child Fetal Neonatal Ed
September 2022
Department of Neonatology, University Medical Centre Groningen Beatrix Children's Hospital, Groningen, The Netherlands.
Objectives: To describe characteristics of neonates with severe neonatal hyperbilirubinaemia (SNH) and to gain more insight in improvable factors that may have contributed to the development of SNH.
Design And Setting: Descriptive study, based on national Dutch perinatal audit data on SNH from 2017 to 2019.
Patients: Neonates, born ≥35 weeks of gestation and without antenatally known severe blood group incompatibility, who developed hyperbilirubinaemia above the exchange transfusion threshold.
Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
Transplant Proc
April 2021
Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Introduction: Survival following lung transplantation (LTx) is limited by the development of chronic lung allograft dysfunction (CLAD), for which there are few effective therapies and no standardized management. Several small studies have demonstrated the effectiveness of extracorporeal photopheresis (ECP) as a therapeutic option for CLAD.
Methods: A retrospective descriptive audit of 12 LTx recipients who received rescue ECP for CLAD over 5 years (2013-2018) at the Alfred Hospital, Melbourne, Australia, was completed.
Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Transfusion
November 2020
Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Background: Alloimmunization can impact both the fetus and neonate.
Study Objectives: (a) calculate the incidence of clinically significant RBC isoimmunization during pregnancy, (b) review maternal management and neonatal outcomes, (c) assess the value of prenatal and postnatal serological testing in predicting neonatal outcomes.
Study Design And Methods: A retrospective audit of consecutive alloimmunized pregnancies was conducted.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!